INDIANAPOLIS — Eli Lilly and Co. on Saturday recalled a single lot of its Glucagon Emergency Kit for Low Blood Sugar, following a patient complaint.
The recall affects only lot D239382D, with an expiration date of April 2022, and was instigated at the patient level after fielding a product complaint reporting that the glucagon vial arrived in liquid form rather than powder form.
“The firm’s investigation indicates that the liquid in this Glucagon vial could be related to the manufacturing process. The use of the liquid form of this product may fail to treat severe low blood sugar due to loss of potency,” the company stated in the recall notice, distributed more broadly by the U.S. Food and Drug Administration on Sunday.
Severe hypoglycemia, or low blood sugar, in patients with diabetes can potentially cause adverse health consequences if not reversed. The adverse effects range from transient, minor complaints to neurological damage, seizures and even death if not promptly treated, the company stated.
According to the news release, the patient who lodged the consumer complaint claimed to experience zero effect from the drug and later reported seizures.
Consumers in possession of the recalled kits are advised to contact The Lilly Answers Center at 1-800-LILLYRX (1-800-545-5979) for return and replacement instructions for the product between 9 a.m. and 7 p.m. EDT, Monday through Friday. They are also advised to contact their health care providers for guidance.
Click here to learn more.
©2021 Cox Media Group